Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
ANAB

Market Cap: $1.6B

AI

AnaptysBio, Inc.

ANAB

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin1.16%

EBITDA Margin25.17%

EBIT Margin24.13%

Pre-tax Margin-11.46%

Net Profit Margin-11.53%

Earnings Yield-1.73%

Valuation Multiples

Price / Book121.25

Price / Sales6.86

Price / Earnings-61.92

PEG0.19

Forward PEG0.27

EV / Sales6.99

EV / EBITDA27.76

EV / Operating Cash Flow362.64

EV / Free Cash Flow368.31

Price / Free Cash Flow361.76

Price / Operating Cash Flow345.15

Cash Flow & Capital

Free Cash Flow / Share$0.15

Operating Cash Flow / Share$0.16

Free Cash Flow Yield0.28%

Capex / Revenue0.03%

Capex / Operating Cash Flow1.54%

Capex / Depreciation0.03

Stock Compensation / Revenue17.69%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio7.58

Quick Ratio7.58

Cash Ratio5.96

Debt / Assets0.84

Debt / Capital0.96

Debt / Equity21.76

Long-Term Debt / Capital0.95

Debt / Market Cap16.67%

Net Debt / EBITDA0.49

Solvency Ratio-0.08

Financial Leverage25.86

Efficiency & Working Capital

Asset Turnover0.70

Fixed Asset Turnover17.45

Inventory Turnover0.00

Receivables Turnover9.03

Payables Turnover-5.07

Days Sales Outstanding40.44

Days Inventory Outstanding0

Days Payables Outstanding-71.92

Operating Cycle40.44

Cash Conversion Cycle112.36

Working Capital Turnover0.79

Returns & Quality

Return on Equity4.43%

Return on Assets-8.13%

Return on Invested Capital14.06%

ROCE14.17%

Return on Tangible Assets-8.13%

Operating Return on Assets11.76%

Income Quality-0.17

Tax Burden1.01

Interest Burden-0.47

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.62B

Invested Capital$287.73M

Working Capital$274.41M

Tangible Asset Value$12.75M

Net Current Asset Value$-828K

Graham Net-Net-$0.39

Book Value / Share$0.44

Tangible Book Value / Share$0.44

Cash / Share$9.98

Financial Health Scores

Piotroski Score5

Altman Z-Score1.85

Revenue$232.39M

EBIT$56.06M

Market Cap$1.63B

Working Capital$274.41M

Retained Earnings$-825.44M

Total Assets$329.68M

Total Liabilities$316.94M